1. Search Result

Search Result

Results for "200619-13-2" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-125331

    Topoisomerase ADC Cytotoxin Cancer
    DRF-1042 is an orally active derivative of Camptothecin. DRF-1042 acts to inhibit DNA topoisomerase I. DRF-1042 shows good anticancer activity against a panel of human cancer cell lines including multi-drug resistance (MDR) phenotype.